Acceptability and Efficacy of the Zemedy App for Irritable Bowel Syndrome

University of Pennsylvania

Status: Completed

Conditions: Irritable Bowel Syndrome

Treatments: Behavioral: Zemedy App for Irritable Bowel Syndrome

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT04170686

833848

Details and patient eligibility

About

The purpose of this research is to assess if a new self-help app for IBS is an acceptable and effective intervention for improving the overall quality of life in patients with Irritable Bowel Syndrome.

Enrollment: 146 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of IBS. Own a smart phone. Speak English

Exclusion criteria

• Under age of consent (18) Diagnosed with another GI disorder (e.g. celiac disease, inflammatory bowel disease)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

146 participants in 2 patient groups

Immediate Treatment

Experimental group

Description:

Participants will have immediate access to the self-help app. They will take 8 weeks to work through the content at their own pace.

Treatment:

Behavioral: Zemedy App for Irritable Bowel Syndrome

Waitlist Control

No Intervention group

Description:

Participants in the waitlist will receive no intervention for 8 weeks, other than a few "check in" emails from study personnel. At the end of 8 weeks, they will be crossed over to the active treatment group and will be given access to the app.